Elektrofi

Acquired

Formulating the future of biologics.

Boston, United States · Founded 2016 · $152.3M raised

Employees
51–200
Founded
2016
Business Model
B2B
Total Funding
$152.3M
Last Round
$112.3M Series COct 2024
Rounds
2
Acquired by
Halozyme TherapeuticsOct 2025 · $750.0M

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Elektrofi is a biopharmaceutical formulation technology company revolutionizing the delivery of biologic therapies by enabling subcutaneous administration of medicines traditionally given intravenously. Using its proprietary Hypercon microparticle platform, Elektrofi partners with biopharmaceutical companies to develop hyper-concentrated, stable formulations of monoclonal antibodies and therapeutic proteins, giving patients more convenient treatment options.

Summary

Elektrofi is a Life Sciences company based in Boston, United States, founded in 2016. It has raised $152.3M in total across 2 rounds, most recently a $112.3M Series C round in Oct 2024. Investors include RA Capital Management, Royalty Pharma and SR One.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

AcquisitionOct 2025

Sign up to see all 3 events

Funding: Series B through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Elektrofi on Indexed.vc
<a href="https://indexed.vc/companies/elektrofi"><img src="https://indexed.vc/api/badge/company/elektrofi" alt="Elektrofi on Indexed.vc" width="260" height="76" /></a>